Laychiluh B. Mekonnen
Adelaide, SA 5001, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions.
Journal: Critical reviews in oncology/hematology
Published: March 22, 2026
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer.
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 19, 2026
Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
Journal: Journal of hematology & oncology
Published: February 03, 2026
Cancer Burden Attributable to Potentially Modifiable Risk Factors in Australia.
Journal: Cancers
Published: August 20, 2025
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2025
A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer.
A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer.
Journal: Investigational new drugs
Published: April 10, 2025
Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: March 03, 2023
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation.
Journal: Bioorganic & medicinal chemistry
Published: November 23, 2022
Discovery of Potent Inhibitors of Cyclin-Dependent Kinases 7 and 9: Design, Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.
Journal: ChemMedChem
Published: October 31, 2022
Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies.
Journal: Drug discovery today
Published: August 05, 2022
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Journal: European journal of medicinal chemistry
Published: December 21, 2020
Discovery of CDK5 Inhibitors through Structure-Guided Approach.
Journal: ACS medicinal chemistry letters
Published: January 29, 2019
Last Updated: 09/26/2026